READ-ONLY DIGITIZATION RESULT
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.
JCO Precis Oncol · 2025-Jan · PMID 39854658
Panel C质量警告待 EXE 对齐验证
distant recurrence-free interval
Figure 3 A, Bar plot demonstrating the proportion of HER2-low tumours and HER2-zero tumours by age groups in BIG 1–98. B, Bar plot demonstrating the proportion of HER2-low tumours and HER2-zero tumours by age group in premenopausal SOFT cohort. C, Kaplan Meier estimate of distant recurrence-free interval by HER2-low status in postmenopausal BIG 1–98 cohort. D, Kaplan Meier estimate of distant recurrence-free interval by HER2-low status in SOFT premenopausal cohort. The hazard ratio characterises HER2-low relative to HER2-zero. Abbreviations: HR, hazard ratio; 95%CI, 95% confidence interval.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:24:40+00:00 |